FDA warns against two artificial tears OTC products

NCPA February 3, 2023

FDA issued a warning Thursday advising consumers and health care practitioners not to purchase and immediately stop using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination. Using contaminated artificial tears increases risk of eye infections that could result in blindness or death. Patients who have signs or symptoms of an eye infection should talk to their health care provider or seek medical care immediately. These OTC products, manufactured by Global Pharma Healthcare Private Limited, are intended to be sterile. Global Pharma initiated a voluntary recall at the consumer level of all unexpired lots of EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears at the FDA’s recommendation.